A5002069785- Heart Failure Treatment and Management
- Potassium and Related Disorders
- Herpesvirus Infections and Treatments
- Meningioma and schwannoma management
- Sleep and related disorders
- Bipolar Disorder and Treatment
- Pharmaceutical Practices and Patient Outcomes
- Cancer Treatment and Pharmacology
- Pesticide Exposure and Toxicity
- Antifungal resistance and susceptibility
- Ethics in Clinical Research
- Diabetes Treatment and Management
- Pancreatic and Hepatic Oncology Research
- Medication Adherence and Compliance
- Neuroscience of respiration and sleep
- Animal Virus Infections Studies
- Privacy-Preserving Technologies in Data
- Peripheral Neuropathies and Disorders
- Breast Lesions and Carcinomas
- Sleep and Wakefulness Research
- Gastric Cancer Management and Outcomes
- Malaria Research and Control
- Lung Cancer Treatments and Mutations
- Colorectal Cancer Treatments and Studies
- Health Systems, Economic Evaluations, Quality of Life
Aetion (United States)
2022-2024
IQVIA (France)
2017-2019
Erasmus MC
2012
Université de Bordeaux
2011
Hôpital Pellegrin
2011
Centre Hospitalier Universitaire de Bordeaux
2011
The United Kingdom (UK) was the first European country to introduce a national immunisation program for shingles (2013-2014). That year, vaccination coverage ranged from 50 64% across UK, but uptake has declined ever since. This study explored determinants of acceptance vaccine in UK.
Background: Vericiguat was developed to treat patients with heart failure (HF). Currently, limited data are available characterize vericiguat-treated in real-world clinical settings. Methods: This retrospective cohort study done using a Japanese hospital administrative database describe the use of vericiguat HF Adult diagnosed prescribed between 1 July 2021 and 30 September 2022 were included. Patient characteristics at initiation treatment, patterns medication use, dose titrations assessed...
Abstract Introduction of new agents for the treatment colorectal cancer (CRC) has been accompanied by publication guidelines. The COLCHIC cohort was set up to evaluate CRC practices and use these innovative expensive agents. Patients initiating at Bordeaux teaching hospital between 1 March 2005 2006 were identified, courses from 31 December studied; 192 patients included, 188 with analysable data: 43 initiated 51 non‐metastatic cancer, 153 366 metastatic eight both cancer. Most treatments...
Abstract Currently, the utilization patterns of medications for heart failure (HF) after worsening HF events remain unelucidated in Japan. Here, we conducted a retrospective cohort study evaluating changes drug 6 months before and hospitalizations HF. The adherence to newly initiated was evaluated based on proportion days covered (PDC) persistence as continuous treatment episodes among new users. included 9091 patients hospitalized between January 2016 September 2019, including 2735 (30.1%)...